In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

    Published: November 25, 2024 | Price: $5,000.00 – $10,500.00

    The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027

    Published: October 18, 2023 | Price: $6,000.00 – $12,000.00

    Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and healthcare-related laboratories, including clinical and analytical laboratories. These include research and development labs, in-process testing labs and quality assurance labs. This new report from Kalorama Information, World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027, examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation....
    In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

    Published: October 18, 2022 | Price: $5,000.00 – $10,000.00

    The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...
    United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

    Published: October 6, 2022 | Price: $5,000.00 – $10,000.00

    The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...
    The U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing

    Published: May 26, 2022 | Price: $5,000.00 – $10,000.00

    Direct to consumer laboratory testing is also known as patient-ordered laboratory testing. A variety of tests are now available for direct to consumer testing. The growing market for direct-to-consumer laboratory testing may promote awareness of health issues and genetic diseases, which will allow patients to take a more proactive role in their healthcare. With advances in technology, the completion of the sequencing of the human genome and the pressures of the pandemic, direct to consumer lab testing is becoming increasingly...
    United States Market for In Vitro Diagnostic (IVD) Tests

    Published: June 7, 2021 | Price: $4,000.00 – $8,000.00

    The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...